Core Technology
We have developed an innovative tumor tissue profiling platform called the GSProTM (Genetic Spatial Profiling) that transforms patient tumor biopsies into a deep, data-rich analysis for pre-clinical and clinical applications. In combination with our proprietary ONCOMaskTM technology and AI, we are developing a workflow that integrates digital pathology with genetic analysis to create a process that almost exclusively uses digital imaging to predict cancer patient response to drug therapy.
The Quantumcyte Advantage
precise
detailed diagnosis facilitates personalized treatment
automated
4x faster than current technologies
complete
4x more detail and data per sample
digital
data analysis with artificial intelligence and machine learning
